Fig. 5From: A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscapePotential intrinsic immune response and escape landscapes in the high-risk and low-risk groups. A Comparison of immunogenomic indicators between the high-risk and low-risk groups. B Mutational activities of four corresponding extracted mutational signatures. C Comparison of four mutational signatures between the high-risk and low-risk groups. D Comparison of enrichment scores of 10 oncogenic pathways between the high-risk and low-risk groups. E Comparison of the expression patterns of MHC molecules, costimulators and coinhibitors between the high-risk and low-risk groupsBack to article page